Philips IntelliSite Pathology Solution now available for primary diagnosis in the US

Contact information

* This field is mandatory

Contact details


Company details


Inquiry details

By specifying your reason for contact we will be able to provide you with a better service.

Developed with the aim to increase efficiency and collaboration in your clinical lab

As the first and currently only digital pathology solution in the U.S. to be marketed for primary diagnostic use, the technology can aid pathologists to view and diagnose digital images of surgical pathology slides. Digital pathology aims to reduce pressure on pathology services by streamlining workflow and extending collaboration with the aim of increasing diagnostic confidence.

What does this mean for me?

Doctor Icon

How can this help my lab to do primary diagnosis?

The availability for primary diagnosis means that with the Philips IntelliSite Pathology Solution you are now allowed to do primary diagnosis on WSI in the US.

World Icon

Will there be consequences for labs in EMEA or APAC?

Not likely. Most labs in EMEA and APAC are already available for primary diagnosis through the IVD-CE label.

Graph Icon

What are the steps I need to follow to go digital?

You can download our whitepaper ‘Going Digital’  on this page as a start. Your local sales specialist also knows how to set up a business case, changes you will have to deal within your organization, getting a demo organized or doing a site visit.

Search Icon

Where can I get more information on your solution?

You can find more information at the bottom of this page.

Document Icon

Can you contact me?

Please follow this link to leave your details in case you want to be contacted by one of our sales specialists.


Contact me

Contact information

* This field is mandatory

Contact details


Company details


Inquiry details

By specifying your reason for contact we will be able to provide you with a better service.

Pathology services are under pressure, digital pathology can help

Click on the button below to download the infographic “Pathology services are under pressure, digital pathology can help”.

Pathology Infographic

Download white paper ‘Going Digital’

How to go Digital in Pathology

Alexi Baidoshvili: “At LabPON, we started using WSI in 2010 and discovered right away that we needed to have a fully digital diagnostics workflow to take advantage of all the benefits. To make the most of our

experience, we want to share our insights with every department of pathology


Gransow Russ

“The availability for Philips IntelliSite Pathology Solution marks a major milestone for innovation in pathology services in the U.S., said Russ Granzow, General Manager of Philips Digital Pathology Solutions. “Not only will it promote increased efficiencies and collaboration between pathologists, but it also opens a complete new dimension towards computational pathology which aims to increase accuracies and ultimately support enhanced patient care.”


- Russ Granzow, General Manager of Philips Digital Pathology

Philips IntelliSite Pathology Solution


Ultra Fast Scanner

For routine use in high volume labs and integrated pathology networks.


Image Management System

Open and scalable design offers optimal intergration into your workflow and IT infrastructure.


Image Management System viewer

Easy access to images and tool/ resources to enable better informed decision-making.




Philips receives FDA clearance to market Philips IntelliSite Pathology Solution for primary diagnostic use in the US



Philips and PathAI team up to improve breast cancer diagnosis using artificial intelligence technology in ‘big data’ pathology research



Philips and LabPON plan to create world’s largest pathology database of annotated tissue images for deep learning



Philips introduces new digital solutions and services to advance pathology at the 2017 USCAP Annual Meeting


Philips enables digitisation of tumour tissue assessment to support UK pathologists to fight cancer



Philips and Spanish hospital Campus de la Salud start implementation of multi-year strategic partnership agreement



Philips teams up with Visiopharm to boost breast cancer diagnosis objectivity through computational pathology



Philips expands its digital pathology solutions portfolio with the acquisition of PathXL



Massachusetts General Hospital embarks on clinical analytical study using Philips IntelliSite Solution to advance digital pathology adoption in the United states.


Philips meets stringent US government security requirements for pathology medical data.


Philips teams up with Genomic Health to utilize innovative digital pathology solutions to optimize pre analytical specimen processing.



Leading global health institutions digitize pathology workflows with Philips to enhance disease diagnoses.


Philips and Mount Sinai Health System collaborate to advance clinical research through new digital pathology database and analytics


Philips and Inspirata, Inc. partner to bring an end-to-end digital pathology workflow to U.S. cancer centers




May 16-18, 2017

Riyadh | Saudi Arabia

June 4-7, 2017

Toronto | Canada

May 22-25, 2017

Pittsburgh, PA | USA

June 20-23, 2017

Belfast | Ireland

Jul 10-11, 2017

Chicago, IL | USA

Sep 2-6, 2017

Amsterdam | The Netherlands

Nov 1-2, 2017

Dubai | United Arab Emirates

Oct 1-3, 2017

San Diego, SF | USA

Nov 10-12, 2017

Thun | Switzerland

Nov 20-23, 2017

Paris | France

Nov 16-18, 2017

Salt Lake City, UT | USA

Nov 30-Dec 1, 2017

London | UK

Nov 26-Dec 1, 2017

Chicago, IL | USA

In the European Union, the Philips IntelliSite Pathology Solution is CE Marked under the European Union's 'In Vitro Diagnostics Directive' for in vitro diagnostic use.

In Canada, the Philips IntelliSite Pathology Solution is licensed by Health Canada for in vitro diagnostic use.

In the United States, the Philips IntelliSite Pathology Solution can be used for in vitro diagnostic purposes.

The Philips IntelliSite Pathology Solution is registered for in vitro diagnostic use in Singapore and Middle East.